Abstract
A 40-year experiential review of the rationale for using the ‘photosensitivity model of epilepsy (PMOE’) in the development of new anti-seizure medicines (ASM)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
